No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes

Diabetes and Metabolism

Volumn 34, Issue 6, 2008, Pages 568-573

  Godbout, A ^a   Hammana, I ^a,b   Potvin, S ^a   Mainville, D ^a   Rakel, A ^a,b   Berthiaume, Y ^a   Chiasson, J L ^a,b,c   Coderre, L ^a,b,d   Rabasa Lhoret, R ^a,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c Montreal Diabetes Research Center   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cystic fibrosis; Diabetes; Glycated haemoglobin

Indexed keywords

FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CAPILLARY BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETIC PATIENT; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; CYSTIC FIBROSIS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; FEMALE; FRUCTOSAMINE; HEALTH STATUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 57049188814     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.05.010     Document Type: Article

References (33)

1. FitzSimmons S.C. The changing epidemiology of cystic fibrosis. J Pediatr 122 (1993) 1-9
2. Lanng S., Thorsteinsson B., Lund-Andersen C., Nerup J., Schiotz P.O., and Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 83 (1994) 72-77
3. Rodman H.M., Doershuk C.F., and Roland J.M. The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine 65 (1986) 389-397
4. Allen H.F., Gay E.C., Klingensmith G.J., and Hamman R.F. Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the US. Diabetes Care 21 (1998) 943-948
5. Costa M., Potvin S., Berthiaume Y., Gauthier L., Jeanneret A., Lavoie A., et al. Diabetes: a major co-morbidity of cystic fibrosis. Diabetes Metab 31 (2005) 221-232
6. Schwarzenberg S.J., Thomas W., Olsen T.W., Grover T., Walk D., Milla C., et al. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 30 (2007) 1056-1061
7. Andersen H.U., Lanng S., Pressler T., Laugesen C.S., and Mathiesen E.R. Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications. Diabetes Care 29 (2006) 2660-2663
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in the diabetes control in insulin dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
9. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
10. Rohlfing C.L., Wiedmeyer H.S., Little R.R., England J.D., Tennil A., and Goldstein D.E. Defining the relationship between plasma glucose and HbA1c. Diabetes Care 25 (2002) 275-278
11. American Diabetes Association. Standards of medical care in diabetes (position statement). Diabetes Care 27 suppl 1 (2004) S15-35
12. Costa M., Potvin S., Hammana I., Malet A., Berthiaume Y., Jeanneret A., et al. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 6 (2007) 376-383
13. Tai M.M. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 17 (1994) 152-154
14. Brennan A.L., Gyi K.M., Wood D.M., Hodson M.E., Geddes D.M., and Baker E.H. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. J Cyst Fibros 5 (2006) 27-31
15. Fogh-Andersen N., and D'Orazio P. Proposal for standardizing direct-reading biosensors for blood glucose. Clin Chem 44 (1998) 655-659
16. Dobson L., Sheldon C.D., and Hattersley A.T. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 21 (2004) 691-696
17. Jefferies C., Solomon M., Perlman K., Sweezey N., and Daneman D. Continuous glucose monitoring in adolescents with cystic fibrosis. J Pediatr 147 (2005) 396-398
18. Lanng S., Thorsteinsson B., Erichsen G., Nerup J., and Koch C. Glucose tolerance in cystic fibrosis. Arch Dis Child 66 (1991) 612-616
19. Levetan C., Want L.L., Weyer C., Strobel S.A., Crean J., Wang Y., et al. Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. Diabetes Care 26 (2003) 1-8
20. American Diabetes Association. Tests of glycemia in diabetes, position statement. Diabetes Care 25 (2002) S97-S99 (suppl)
21. Wagener J.S., McNeill G.C., Taussig L.M., Corrigan J.J., and Lemen R. Ferrokinetic and hematologic studies in cystic fibrosis patients. Am J Pediatr Hematol Oncol 5 (1983) 153-160
22. Pond M.N., Morton A.M., and Conway S.P. Functional iron deficiency in adults with cystic fibrosis. Respir Med 90 (1996) 409-413
23. Reid D.W., Withers N.J., Francis L., Wilson J.W., and Kotsimbos T.C. Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection. Chest 121 (2002) 48-54
24. Tarim O., Kucukerdogan A., Gunay U., Eralp O., and Ercan I. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int 41 (1999) 357-362
25. Goldstein D.E., Little R.R., Lorenz R.A., Malone J.I., Nathan D., Peterson C.M., et al. Tests of glycemia in diabetes. Diabetes Care 27 (2004) 1761-1773
26. Davie S.J., Gould B.J., and Yudkin J.S. Effect of vitamin C on glycosylation of proteins. Diabetes 41 (1992) 167-173
27. Ceriello A., Giugliano D., Quatraro A., Donzella C., Dipalo G., and Lefebvre P.J. Vitamin E reduction of protein glycosylation in diabetes: new prospect for prevention of diabetic complications?. Diabetes Care 14 (1991) 68-72
28. Gaede P., Poulsen H.E., Parving H.H., and Pedersen O. Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients. Diabet Med 18 (2001) 756-760
29. Panzer S., Kronik G., Lechner K., Bettelheim P., Neumann E., and Dudczak R. glycated hemoglobins (GHb): an index of red cell survival. Blood 59 (1982) 1348-1350
30. Polgreen P.M., Putz D., and Stapleton J.T. Inaccurate glycated hemoglobin A1c measurements in human immunodeficiency virus-positive patients with diabetes mellitus. Clin Infect Dis 37 (2003) E53
31. Diop M.-E., Bastard J.-P., Meunier N., Thénevet S., Maachi M., Capeau J., et al. Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients. Aids Res Hum Retroviruses 22 (2006) 1242-1247
32. Lindsey C.C., Carter A.W., Mangum S., Greene D., Richardson A., Brown S.J., et al. A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care. Diabetes Technol Ther 6 (2004) 370-377
33. Dobson L., Sheldon C.D., and Hattersley A.T. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care 26 (2003) 1940-1941